Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.54 |
| ▸ | NOS3 | P29474 | 2/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.50 |
| ▸ | NOS2 | P35228 | 2/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.38 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.38 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25660439 | 1.00 | SLC7A5 (0.54) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL21526182 | 1.00 | SLC7A5 (0.54) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL8892097 | 0.88 | NOS3 (0.53) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL9423322 | 0.88 | NOS3 (0.53) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL17434420 | 0.88 | NOS3 (0.53) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| Hydrochloric Acid SCHEMBL8893490 | 0.85 | NOS3 (0.52) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL23935435 | 0.84 | NOS3 (0.49) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL21837379 | 0.84 | NOS3 (0.49) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL21837723 | 0.84 | NOS3 (0.49) | SLC7A5NOS3NOS1NOS2SLC1A3 | |
| SCHEMBL21837378 | 0.84 | NOS3 (0.49) | SLC7A5NOS3NOS1NOS2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH, INC. (JP) | 2023-05-11 | — | — | US | disclosed |
| WO-2012048013-A2 | PHOSPHORODIAMIDATE DERIVATIVES OF GUANOSINE NUCLEOSIDE COMPOUNDS FOR TREATMENT OF VIRAL INJECTIONS | INHIBITEX, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | SLC7A5 647/4885NOS3 3743/4885NOS1 4403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.